The pancreato-biliary surgery group conducts surgical treatment of the pancreas and biliary tract.
Conducting surgery for anatomically complex pancreato-biliary diseases requires a high level of technological knowledge and passion for diagnosis and treatment.
Surgical treatment is the only approach to be able to expect cure of bile duct and pancreatic cancer. At the time of diagnosis, however, distant metastasis or infiltration of the cancer in surrounding organs are often detected. Our group’s ingenuity and development of operative methods allow us to perform resection in cases, which would be difficult to be treated at other institutions. Further, despite anticancer drug treatment having already begun in patients considered inoperable, we proactively conduct surgery when the cancer hasn’t progressed for an extended period, and have cases where survival has been greatly extended. Given these results, our group is now a leader in this field.
Although the treatment outcomes for bile duct and pancreatic cancer vary widely at each institution, research shows that the number of successful treatments increases in institutions with a higher number of case volumes.
Even if you are diagnosed with advanced cancer of bile duct or pancreas, do not lose hope and consider contacting us.
We operate not only on major hepatic resections and pancreatoduodenectomies, but also perform resections of the portal vein and hepatic artery if needed, leading to a high rate of treatment success.
Recently, our group also performs operations after an inoperable diagnosis, in which chemotherapy is used to shrink the size of the tumor, or in cases where there is no significant change in tumor size.
Given that symptoms of pancreatic cancer do not easily appear, there are a number of unresectable cases with already progressed stage. For the refractory cancer, our group has actively challenged to perform radical operation with vascular resection and reconstruction, which has lead to improved treatment outcomes. In particular, we have introduced DP-CAR (distal pancreatectomy with en-bloc celiac axis resection) for the treatment of locally advanced pancreatic cancer, and have acquired excellent treatment outcomes.
Furthermore, we have demonstrated the good outcomes after vascular resection following chemotherapy in response cases, which was initially diagnosed as impossible for curative resection.
We perform minimally invasive surgery for benign or borderline malignant deseases, such as intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN) of the pancreas, and pancreatic solid-pseudopapillary neoplasm (SPN). As an example of minimally invasive surgery, we perform bile duct resection, partial pancreatectomy, distal pancreatectomy, spleen preserving distal pancreatectomy and splenectomy with laparoscopy.
Function preserving surgery aims to maintain as much as non-affected organ, the pancreatic head resection with preserving of duodenum and biliary tract is one example. Compared with pancreatoduodenectomy, the procedure demands high-level technical skills and experiences to provide good quality of life after surgery. We are one of the few facilities, which can offer the challenging procedure in Japan.